Since the beginning of 2024, medicines produced in India have accounted for 8.3% of the total volume of medicines imported to Ukraine.
The State Service for Medicinal Products and Drug Control (Goslexluzhba) informed Interfax-Ukraine that since the beginning of 2024, 3213 series (32824807 packages) from 65 Indian pharmaceutical manufacturers have been submitted for state quality control, which makes up 8.3% of the total volume of medicines imported to Ukraine.
At the same time during 2022-2023 10924 series of medicinal products manufactured in India were submitted for state quality control, including 4715 in 2022 and 6209 in 2023, which is 54705914 and 51309132 packages respectively.
In addition, the State Service of Medicinal Products with reference to the data of the State Register of Medicinal Products reported that since the beginning of 2024 Indian pharmaceutical manufacturers have registered in Ukraine a little more than 100 drugs (excluding active pharmaceutical ingredients, API – IF-U), currently in Ukraine are registered 1999 drugs manufactured in India, in 2023 in Ukraine were registered 1895 Indian drugs, in 2022 – 1709, in 2021 – 1472, in 2020 – 1165.
Thus, the dynamics of registration of Indian medicinal products in Ukraine over the last five years is slowing down: if the number of registered medicinal products manufactured in India in 2021 was 26.2% higher than a year earlier, then at the end of 2023 – only by 10.9%.
The production of basic pharmaceuticals in Ukraine in January-August 2019 increased by 8.8% compared to the same period last year, the State Statistics Service has reported. According to the report, in particular, production of drugs packaged for retail sale containing mixed or unmixed products increased by 5.6% in January-August compared to the same period of the previous year.
At the same time, the production of medicines containing antibiotics decreased by 3.1% compared with January-August 2018. The production of drugs intended for therapeutic or prophylactic use and containing corticosteroid hormones, their derivatives and structural analogues that do not contain antibiotics, fell by 15%, respectively.
As reported, production of basic pharmaceutical goods and pharmaceuticals in Ukraine in January-August 2018 decreased by 2.2% compared to the same period in 2017.
The Embassy of India in Kyiv in cooperation with the Pharmaceuticals Export Promotion Council of India (Pharmexcil) and the Indian Pharmaceutical Manufacturers Association (IPMA) will hold an annual business seminar in Ukraine to promote and demonstrate the potential of India in the pharmaceutical manufacturing sectors, Indian Ambassador to Ukraine Partha Satpathy has stated at a press conference at Interfax-Ukraine. “Pharmexcil is the Pharmaceuticals Export Promotion Council of India. The main task of this organization is to unite all important pharmaceutical manufacturers in India. The council cooperates with the government, represents the interests of manufacturers in exports, in particular brings pharmaceutical products in compliance with the requirements of the WHO and the importing country,” the ambassador said.
President of the Indian Pharmaceutical Manufacturers Association (IPMA) Dr. Menon, in turn, said that Pharmexcil plans to present several projects in Ukraine.
“Pharmexcil wants to find partners in Ukraine in the field of Ayurveda, clinical trials and create a joint venture for production of medicines,” he said.
The Indian ambassador noted that India is the third largest exporter of pharmaceutical products to Ukraine following Germany and France in terms of value, while Indian pharmaceutical companies supply high-quality products at a very good and competitive price.
